Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design.
作者信息
Torzewski Jan, Sheriff Ahmed, Filep Janos G, Peter Karlheinz, Ridker Paul M
机构信息
Department of Cardiology, Cardiovascular Center Oberallgaeu-Kempten, Clinic Association Allgaeu, Kempten, Germany.
Medical Department, Charité University Medicine, Berlin, Germany.
出版信息
Front Cardiovasc Med. 2025 Jun 26;12:1644576. doi: 10.3389/fcvm.2025.1644576. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design.社论：临床医学中针对白细胞介素-1β/白细胞介素-6/ C反应蛋白通路——临床试验设计路线图
Front Cardiovasc Med. 2025 Jun 26;12:1644576. doi: 10.3389/fcvm.2025.1644576. eCollection 2025.
2
Comprehensive Review: Unveiling the Pro-Oncogenic Roles of IL-1ß and PD-1/PD-L1 in NSCLC Development and Targeting Their Pathways for Clinical Management.全面综述：揭示 IL-1ß 和 PD-1/PD-L1 在 NSCLC 发展中的致癌作用，并针对其通路进行临床管理。
Int J Mol Sci. 2023 Jul 17;24(14):11547. doi: 10.3390/ijms241411547.
3
Interleukin-1β in circulating mononuclear cells predicts steatotic liver disease improvement after weight loss in subjects with obesity and prediabetes or type 2 diabetes.循环单核细胞中的白细胞介素-1β可预测肥胖及糖尿病前期或2型糖尿病患者体重减轻后脂肪性肝病的改善情况。
Cardiovasc Diabetol. 2025 Jun 13;24(1):247. doi: 10.1186/s12933-025-02706-8.
4
Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.精神分裂症急性和慢性期外周细胞因子及相关炎症蛋白浓度的变化模式：一项系统评价和网状Meta分析
Lancet Psychiatry. 2023 Apr;10(4):260-271. doi: 10.1016/S2215-0366(23)00025-1. Epub 2023 Feb 27.
5
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.帕金森病外周炎症细胞因子水平的改变：系统评价和荟萃分析。
JAMA Neurol. 2016 Nov 1;73(11):1316-1324. doi: 10.1001/jamaneurol.2016.2742.
6
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion.白细胞介素1受体辅助蛋白（IL1RAP）在人类动脉粥样硬化中的表达：新型抗体降低血管炎症和黏附的靶点
J Am Heart Assoc. 2025 May 20;14(10):e039557. doi: 10.1161/JAHA.124.039557. Epub 2025 May 15.
7
Clinical outcomes of anti-inflammatory therapies inhibiting the NLRP3/IL-1β/IL-6/CRP pathway in coronary artery disease patients: a systemic review and meta-analysis of 37,056 individuals from 32 randomized trials.抑制NLRP3/IL-1β/IL-6/CRP通路的抗炎疗法在冠心病患者中的临床结局：对来自32项随机试验的37056名个体的系统评价和荟萃分析
Inflamm Res. 2025 Jun 30;74(1):99. doi: 10.1007/s00011-025-02058-9.
8
A Mechanistic Analysis of the Neural Modulation of the Inflammatory System Through Vagus Nerve Stimulation: A Systematic Review and Meta-analysis.通过迷走神经刺激对炎症系统进行神经调节的机制分析：系统评价与荟萃分析
Neuromodulation. 2025 Jan;28(1):43-53. doi: 10.1016/j.neurom.2024.03.002. Epub 2024 May 25.
9
"The Ameliorative Effect of Interleukin-17A Neutralization on Doxorubicin-Induced Cardiotoxicity by Modulating the NF-κB/NLRP3/Caspase-1/IL-1β Signaling Pathway in Rats".白细胞介素-17A中和通过调节大鼠体内NF-κB/NLRP3/半胱天冬酶-1/白细胞介素-1β信号通路对阿霉素诱导的心脏毒性的改善作用
Inflammation. 2025 Mar 11. doi: 10.1007/s10753-024-02187-z.
10
Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts.白细胞介素-1受体拮抗剂的循环水平与心血管疾病风险：六项基于人群队列的荟萃分析
Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1222-1227. doi: 10.1161/ATVBAHA.117.309307. Epub 2017 Apr 20.
本文引用的文献
1
Colchicine for Cardiovascular Disease: Navigating the Gap Between Evidence, Guidelines, and Clinical Practice.用于心血管疾病的秋水仙碱：跨越证据、指南与临床实践之间的差距
J Am Coll Cardiol. 2025 Jun 10;85(22):2092-2095. doi: 10.1016/j.jacc.2025.03.536.
2
Selective C-reactive protein apheresis in acute myocardial infarction: rationale and design of a prospective international randomized controlled trial.急性心肌梗死中的选择性C反应蛋白血液净化疗法：一项前瞻性国际随机对照试验的基本原理与设计
Coron Artery Dis. 2025 Aug 1;36(5):428-433. doi: 10.1097/MCA.0000000000001521. Epub 2025 Jun 25.
3
Timing the Taming of Vascular Inflammation.把握血管炎症的控制时机。
N Engl J Med. 2025 Feb 13;392(7):712-714. doi: 10.1056/NEJMe2416329.
4
Colchicine in Acute Myocardial Infarction.秋水仙碱与急性心肌梗死
N Engl J Med. 2025 Feb 13;392(7):633-642. doi: 10.1056/NEJMoa2405922. Epub 2024 Nov 17.
5
Do Interleukin-1 and Interleukin-6 Antagonists Hold Any Place in the Treatment of Atherosclerotic Cardiovascular Disease and Related Co-Morbidities? An Overview of Available Clinical Evidence.白细胞介素-1和白细胞介素-6拮抗剂在动脉粥样硬化性心血管疾病及相关合并症的治疗中占有一席之地吗？现有临床证据概述。
J Clin Med. 2023 Feb 6;12(4):1302. doi: 10.3390/jcm12041302.
6
A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.一种新型的磷酸胆碱类似物抑制 C 反应蛋白的促炎构象变化。
EMBO Mol Med. 2023 Jan 11;15(1):e16236. doi: 10.15252/emmm.202216236. Epub 2022 Dec 5.
7
Targeting conformational changes in C-reactive protein to inhibit pro-inflammatory actions.靶向 C 反应蛋白的构象变化以抑制促炎作用。
EMBO Mol Med. 2023 Jan 11;15(1):e17003. doi: 10.15252/emmm.202217003. Epub 2022 Dec 5.
8
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial.在高动脉粥样硬化风险患者中使用 ziltivekimab 抑制白介素-6（RESCUE）：一项双盲、随机、安慰剂对照、2 期试验。
Lancet. 2021 May 29;397(10289):2060-2069. doi: 10.1016/S0140-6736(21)00520-1. Epub 2021 May 17.
9
Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease.白细胞介素-6 信号转导与抗白细胞介素-6 治疗在心血管疾病中的应用
Circ Res. 2021 May 28;128(11):1728-1746. doi: 10.1161/CIRCRESAHA.121.319077. Epub 2021 May 17.
10
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study.C反应蛋白血液滤过术作为急性心肌梗死的抗炎治疗：CAMI-1研究结果
Front Cardiovasc Med. 2021 Mar 10;8:591714. doi: 10.3389/fcvm.2021.591714. eCollection 2021.
Zotero 插件